Plasma Levels of Citalopram in Depressed Patients With Hepatitis C

Hepatitis C affects an estimated 4 million Americans and 100 million people worldwide. Rates of depression are higher than that seen in the general population. Antidepressant therapy is often initiated at lower doses in patients with liver disease because of concerns about impaired metabolism and cl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychosomatics (Washington, D.C.) D.C.), 2004-01, Vol.45 (1), p.29-33
Hauptverfasser:	Gleason, Ondria C., Yates, William R., Philipsen, Michelle A., Daniel Isbell, M., Pollock, Bruce G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antidepressive Agents, Second-Generation - blood Antidepressive Agents, Second-Generation - therapeutic use Biological and medical sciences Citalopram - blood Citalopram - therapeutic use Depressive Disorder - blood Depressive Disorder - complications Depressive Disorder - drug therapy Dose-Response Relationship, Drug Drug toxicity and drugs side effects treatment Female Hepatitis C - blood Hepatitis C - complications Humans Male Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Serotonin Uptake Inhibitors - blood Serotonin Uptake Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!